Study to Evaluate Adverse Events and Movement of Lemzoparlimab in Body When Used Intravenously (IV) With Azacitidine Subcutaneously or IV and Venetoclax Orally in Participants With Acute Myeloid Leukemia and With Azacitidine With or Without Venetoclax in Participants With Myelodysplastic Syndrome
PHASE1
Acute myeloid leukemia (AML) is one of the most aggressive blood cancers, w...
Status
Terminated
Location
University of Alabama at Birmingham - Main /ID# 227071
A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS)
PHASE3
This phase3 study is a randomized, controlled, open-label, multicenter stud...
Status
Terminated
Location
The First Affiliated Hospital Of Bengbu Medical College